ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange

Core Viewpoint - ASP Isotopes Inc. is advancing its strategic initiatives by obtaining a secondary listing on the Johannesburg Stock Exchange (JSE) while pursuing the acquisition of Renergen Limited to enhance its position in the critical materials market [2][3][4]. Group 1: JSE Listing - The JSE has approved the listing of ASP Isotopes' common stock on its Main Board under the name "ASPI" with trading expected to commence on August 27, 2025 [2]. - The company will maintain its primary listing on the Nasdaq Capital Market, and the secondary listing will not affect its issued share capital [2]. Group 2: Acquisition of Renergen - ASP Isotopes intends to acquire Renergen, with shareholders receiving 0.09196 new ASP Isotopes shares for each Renergen share held, aiming to create a global critical materials company [3]. - The acquisition was approved by 99.8% of Renergen's voting shareholders on July 10, 2025, but is subject to remaining offer conditions [3]. - The acquisition is expected to close in the third quarter of 2025, and the secondary listing on the JSE is not contingent upon the completion of this acquisition [3][5]. Group 3: Strategic Goals and Financial Projections - The combination of ASP Isotopes and Renergen aims to create a leader in producing critical materials, including electronic gases and isotopically enriched gases, with significant synergies anticipated from 2026 [4]. - The combined entity is projected to generate over $300 million in EBITDA by 2030, driven by sales of isotopes, helium, and LNG in the South African energy market [5]. - The strategic focus includes enhancing the supply chain for isotopes and helium, which are deemed critically important by Western governments [6]. Group 4: Company Overview - ASP Isotopes is dedicated to developing technology for isotope production, focusing on healthcare and technology industries, with facilities located in Pretoria, South Africa [9][10]. - The company employs proprietary technology, the Aerodynamic Separation Process, to produce highly enriched isotopes and plans to enrich isotopes for the nuclear energy sector [9][10].